Cristobal Risquez Cordovez, MD
Critical Care Medicine · Miami, FLNPI 1083980031
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,676 and has fallen 89.8% since, to $171 in 2023.
Across 127 payments — averaging $26.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$676
- AstraZeneca$493
- Boehringer Ingelheim$482
- Actelion Pharmaceuticals US, Inc.$248
- Regeneron Healthcare Solutions, Inc.$238
- Mallinckrodt Hospital Products Inc.$162
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,400100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 19 | $676 |
| AstraZeneca | 25 | $493 |
| Boehringer Ingelheim | 12 | $482 |
| Actelion Pharmaceuticals US, Inc. | 6 | $248 |
| Regeneron Healthcare Solutions, Inc. | 14 | $238 |
| Mallinckrodt Hospital Products Inc. | 6 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $152 |
| Fisher & Paykel Healthcare Inc | 1 | $151 |
| Philips North America LLC | 6 | $135 |
| Sanofi | 5 | $113 |
| United Therapeutics Corporation | 4 | $94 |
| Insmed, Inc. | 4 | $80 |
| Baxter Healthcare | 4 | $74 |
| Amgen | 3 | $68 |
| Genentech USA, Inc. | 3 | $62 |
| Pfizer | 2 | $37 |
| Nabriva Therapeutics, PLC | 2 | $34 |
| Grifols USA, LLC | 1 | $19 |
| Novartis | 1 | $18 |
| Merck | 1 | $18 |
| Phadia US Inc. | 1 | $16 |
| Mylan Specialty L.p. | 1 | $16 |
| Advanced Respiratory, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FISHER & PAYKEL HEALTHCARE$754
- TRELEGY ELLIPTA$242
- NUCALA$125
- UPTRAVI$122
- OPSUMIT$122
- OFEV$116
How this compares
$3,400 in reported general payments places this provider in the 85th percentile of 618 critical care medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Miami
- Michael CamposMiami$70K
- Alexandre AbreuMiami$34K
- Daniel KettMiami$14K
- Louis GuzziOrlando$635K
- Fortune AlabiKissimmee$587K
- Debabrata BandyopadhyayTampa$398K
- Fred UmehKissimmee$371K
- Amit TandonWesley Chapel$338K
- Omid ZadOrlando$325K
- Eddy GutierrezJacksonville$315K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.